{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T18:21:09Z","timestamp":1792261269362,"version":"4.4.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T00:00:00Z","timestamp":1600128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM115617"],"award-info":[{"award-number":["GM115617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["LCF\/PR\/PR18\/51130007"],"award-info":[{"award-number":["LCF\/PR\/PR18\/51130007"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["MSD-2017"],"award-info":[{"award-number":["MSD-2017"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-110496RB-C21"],"award-info":[{"award-number":["PID2019-110496RB-C21"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-110496RB-C22"],"award-info":[{"award-number":["PID2019-110496RB-C22"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2016-77871-C2-1-R"],"award-info":[{"award-number":["SAF2016-77871-C2-1-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["SAF2016-77871-C2-2-R"],"award-info":[{"award-number":["SAF2016-77871-C2-2-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.metabol.2020.154352","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T06:48:48Z","timestamp":1599634128000},"page":"154352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice"],"prefix":"10.1016","volume":"113","author":[{"given":"Beatriz","family":"Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina M.","family":"Fern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Parrado-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Gonz\u00e1lez-Casimiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Postigo-Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen D.","family":"Lobat\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm A.","family":"Leissring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"C\u00f3zar-Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2020.154352_bb0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/physiol.00048.2018","article-title":"Hepatic insulin clearance: mechanism and physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiology."},{"key":"10.1016\/j.metabol.2020.154352_bb0010","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism","volume":"443","author":"Shen","year":"2006","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2020.154352_bb0015","first-page":"608","article-title":"Insulin degradation: progress and potential","volume":"19","author":"Duckworth","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2020.154352_bb0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/10409238.2017.1337707","article-title":"Multiple functions of insulin-degrading enzyme: a metabolic crosslight?","volume":"52","author":"Tundo","year":"2017","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.metabol.2020.154352_bb0025","doi-asserted-by":"crossref","first-page":"e20818","DOI":"10.1371\/journal.pone.0020818","article-title":"Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance","volume":"6","author":"Abdul-Hay","year":"2011","journal-title":"PloS One."},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2020.154352_bb0030","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2020.154352_bb0035","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s00125-010-1861-2","article-title":"Expression analysis of loci associated with type 2 diabetes in human tissues","volume":"53","author":"Cotsapas","year":"2010","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2020.154352_bb0040","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/hmg\/9.14.2149","article-title":"Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats","volume":"9","author":"Fakhrai-Rad","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2020.154352_bb0045","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2337\/diabetes.48.5.1175","article-title":"A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians","volume":"48","author":"Elbein","year":"1999","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154352_bb0050","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1080\/15384101.2015.1046647","article-title":"Modulation of insulin degrading enzyme activity and liver cell proliferation","volume":"14","author":"Pivovarova","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.metabol.2020.154352_bb0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/07315724.2003.10719326","article-title":"Insulin clearance in obesity","volume":"22","author":"Valera Mora","year":"2003","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.metabol.2020.154352_bb0060","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1210\/jc.2009-0212","article-title":"Thyroid hormone-related regulation of gene expression in human fatty liver","volume":"94","author":"Pihlajamaki","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154352_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.08.001","article-title":"Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice","volume":"88","author":"Villa-Perez","year":"2018","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2020.154352_bb0070","first-page":"1167","article-title":"Insulin degrading enzyme is up-regulated in pancreatic beta cells by insulin treatment","volume":"33","author":"Fernandez-Diaz","year":"2018","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.metabol.2020.154352_bb0075","doi-asserted-by":"crossref","first-page":"E805","DOI":"10.1152\/ajpendo.00040.2019","article-title":"Pancreatic beta-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and beta-cell functional immaturity","volume":"317","author":"Fernandez-Diaz","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154352_bb0080","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1194\/jlr.M001206","article-title":"A role of apolipoprotein D in triglyceride metabolism","volume":"51","author":"Perdomo","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2020.154352_bb0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-0716-0385-7_15","article-title":"Assessment of insulin tolerance in vivo in mice","volume":"2128","author":"Cozar-Castellano","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.metabol.2020.154352_bb0090","doi-asserted-by":"crossref","first-page":"9802","DOI":"10.1002\/jcp.27667","article-title":"Hyperinsulinemia is associated with increasing insulin secretion but not with decreasing insulin clearance in an age-related metabolic dysfunction mice model","volume":"234","author":"Kurauti","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2020.154352_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/JOE-15-0483","article-title":"Acute exercise restores insulin clearance in diet-induced obese mice","volume":"229","author":"Kurauti","year":"2016","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2020.154352_bb0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-0716-0385-7_19","article-title":"Assessment of insulin tolerance ex vivo","volume":"2128","author":"Cozar-Castellano","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.metabol.2020.154352_bb0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"10.1016\/j.metabol.2020.154352_bb0110","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1210\/en.2006-0541","article-title":"Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism","volume":"147","author":"Qu","year":"2006","journal-title":"Endocrinology."},{"key":"10.1016\/j.metabol.2020.154352_bb0115","first-page":"149","article-title":"Insulin-degrading enzyme","volume":"19","author":"Authier","year":"1996","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.metabol.2020.154352_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1210\/edrv-9-3-319","article-title":"Insulin degradation: mechanisms, products, and significance","volume":"9","author":"Duckworth","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2020.154352_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2020.154352_bb0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","article-title":"Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR)","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154352_bb0135","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1152\/ajpendo.2000.278.3.E501","article-title":"Roles of insulin resistance and obesity in regulation of plasma insulin concentrations","volume":"278","author":"Jones","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154352_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00592-013-0511-9","article-title":"Differences in insulin clearance between metabolically healthy and unhealthy obese subjects","volume":"51","author":"Marini","year":"2014","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2020.154352_bb0145","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/db19-0098","article-title":"Hypothesis: role of reduced hepatic insulin clearance in the pathogenesis of type 2 diabetes","volume":"68","author":"Bergman","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154352_bb0150","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa070","article-title":"Reduced insulin clearance and insulin-degrading enzyme activity contribute to hyperinsulinemia in African Americans","volume":"105","author":"Fosam","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2020.154352_bb0155","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/JOE-13-0177","article-title":"Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing","volume":"219","author":"Brandimarti","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2020.154352_bb0160","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1017\/S0007114511006623","article-title":"The effects of a cafeteria diet on insulin production and clearance in rats","volume":"108","author":"Castell-Auvi","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.metabol.2020.154352_bb0165","doi-asserted-by":"crossref","first-page":"e95399","DOI":"10.1371\/journal.pone.0095399","article-title":"Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice","volume":"9","author":"Wei","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.metabol.2020.154352_bb0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/oby.22418","article-title":"Adiposity-independent effects of aging on insulin sensitivity and clearance in mice and humans","volume":"27","author":"Ehrhardt","year":"2019","journal-title":"Obesity."},{"key":"10.1016\/j.metabol.2020.154352_bb0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.carpath.2013.03.006","article-title":"Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice","volume":"22","author":"Caravaggio","year":"2013","journal-title":"Cardiovasc Pathol Off J Soc Cardiovasc Pathol"},{"key":"10.1016\/j.metabol.2020.154352_bb0180","doi-asserted-by":"crossref","first-page":"20622","DOI":"10.1016\/S0021-9258(17)32038-0","article-title":"Androgen and glucocorticoid receptors interact with insulin degrading enzyme","volume":"269","author":"Kupfer","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2020.154352_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0092-8674(88)90051-7","article-title":"Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells","volume":"55","author":"Thorens","year":"1988","journal-title":"Cell."},{"key":"10.1016\/j.metabol.2020.154352_bb0190","doi-asserted-by":"crossref","first-page":"12317","DOI":"10.1073\/pnas.95.21.12317","article-title":"Normal hepatic glucose production in the absence of GLUT2 reveals an alternative pathway for glucose release from hepatocytes","volume":"95","author":"Guillam","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2020.154352_bb0195","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/db11-0815","article-title":"Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition","volume":"61","author":"Dufer","year":"2012","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154352_bb0200","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1172\/JCI65538","article-title":"Hepatic glucose sensing is required to preserve beta cell glucose competence","volume":"123","author":"Seyer","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2020.154352_bb0205","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.49.10.1635","article-title":"Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization","volume":"49","author":"Burcelin","year":"2000","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154352_bb0210","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.49.10.1643","article-title":"Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice","volume":"49","author":"Burcelin","year":"2000","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2020.154352_bb0215","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-291X(88)80583-7","article-title":"Cellular localization of insulin-degrading enzyme in rat liver using monoclonal antibodies specific for this enzyme","volume":"155","author":"Akiyama","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2020.154352_bb0220","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","article-title":"Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer\u2019s disease?","volume":"48","author":"Pivovarova","year":"2016","journal-title":"Ann Med"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952030216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952030216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T09:52:29Z","timestamp":1656064349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952030216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":44,"alternative-id":["S002604952030216X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154352","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic insulin-degrading enzyme regulates glucose and insulin homeostasis in diet-induced obese mice","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154352"}}